Arcutis Biotherapeutics, Inc. (ARQT) › Shareholders' EquityArcutis Biotherapeutics, Inc. (ARQT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$4.99M2018: -$23.99M2019: -$65.03M2020: $270.62M2021: $297.68M2022: $209.58M2023: $88.67M2024: $157.54M2025: $189.48M$189.48M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$189.48M+20.3%2024$157.54M+77.7%2023$88.67M-57.7%2022$209.58M-29.6%2021$297.68M+10.0%2020$270.62M+516.2%2019-$65.03M-171.1%2018-$23.99M-380.4%2017-$4.99M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share